These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22749631)

  • 1. Quality control of high-dose-rate brachytherapy: treatment delivery analysis using statistical process control.
    Able CM; Bright M; Frizzell B
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):828-33. PubMed ID: 22749631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al(2)O(3):C dosimetry and a novel statistical error decision criterion.
    Kertzscher G; Andersen CE; Siebert FA; Nielsen SK; Lindegaard JC; Tanderup K
    Radiother Oncol; 2011 Sep; 100(3):456-62. PubMed ID: 21963285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
    Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
    J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.
    Fuller DB; Naitoh J; Lee C; Hardy S; Jin H
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1588-97. PubMed ID: 18374232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrated system for clinical treatment verification of HDR prostate brachytherapy combining source tracking with pretreatment imaging.
    Smith RL; Hanlon M; Panettieri V; Millar JL; Matheson B; Haworth A; Franich RD
    Brachytherapy; 2018; 17(1):111-121. PubMed ID: 28958735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verification of high dose rate brachytherapy dose distributions with EBT3 Gafchromic film quality control techniques.
    Palmer AL; Nisbet A; Bradley D
    Phys Med Biol; 2013 Feb; 58(3):497-511. PubMed ID: 23306148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
    Grills IS; Martinez AA; Hollander M; Huang R; Goldman K; Chen PY; Gustafson GS
    J Urol; 2004 Mar; 171(3):1098-104. PubMed ID: 14767279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of anatomy-based dwell position and inverse optimization in high-dose-rate brachytherapy of prostate cancer: a dosimetric comparison to a conventional cylindrical dwell position, geometric optimization, and dose-point optimization.
    Yoshioka Y; Nishimura T; Kamata M; Harada H; Kanazawa K; Fuji H; Murayama S
    Radiother Oncol; 2005 Jun; 75(3):311-7. PubMed ID: 15890425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Brachytherapy boost irradiation in the treatment of high risk, localised prostate cancer. Initial national experience in Hungary].
    Agoston P; Major T; Somogyi A; Szûcs M; Danczig A; Lövey J; Polgár C; Fodor J; Németh G; Kásler M
    Magy Onkol; 2004; 48(1):81-8. PubMed ID: 15105901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and testing of a phantom and instrumented gynecological applicator based on GaN dosimeter for use in high dose rate brachytherapy quality assurance.
    Guiral P; Ribouton J; Jalade P; Wang R; Galvan JM; Lu GN; Pittet P; Rivoire A; Gindraux L
    Med Phys; 2016 Sep; 43(9):5240. PubMed ID: 27587055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of an in vivo dosimetry-based source tracking method for afterloading brachytherapy - A phantom study.
    Jørgensen EB; Kertzscher G; Buus S; Bentzen L; Hokland SB; Rylander S; Tanderup K; Johansen JG
    Med Phys; 2021 May; 48(5):2614-2623. PubMed ID: 33655555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo dosimetry for gynaecological brachytherapy using a novel position sensitive radiation detector: feasibility study.
    Reniers B; Landry G; Eichner R; Hallil A; Verhaegen F
    Med Phys; 2012 Apr; 39(4):1925-35. PubMed ID: 22482614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of a phantom for the quality control of high dose rate 192Ir source used in brachytherapy.
    Ochoa R; Gómez F; Ferreira IH; Gutt F; de Almeida CE
    Radiother Oncol; 2007 Feb; 82(2):222-8. PubMed ID: 17267060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of finite patient dimensions and tissue inhomogeneities on dosimetry planning of 192Ir HDR breast brachytherapy: a Monte Carlo dose verification study.
    Pantelis E; Papagiannis P; Karaiskos P; Angelopoulos A; Anagnostopoulos G; Baltas D; Zamboglou N; Sakelliou L
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1596-602. PubMed ID: 15817368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method for verification of treatment delivery in HDR prostate brachytherapy using a flat panel detector for both imaging and source tracking.
    Smith RL; Haworth A; Panettieri V; Millar JL; Franich RD
    Med Phys; 2016 May; 43(5):2435. PubMed ID: 27147354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate HDR brachytherapy catheter displacement between planning and treatment delivery.
    Whitaker M; Hruby G; Lovett A; Patanjali N
    Radiother Oncol; 2011 Dec; 101(3):490-4. PubMed ID: 21889221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance assessment of the BEBIG MultiSource high dose rate brachytherapy treatment unit.
    Palmer A; Mzenda B
    Phys Med Biol; 2009 Dec; 54(24):7417-34. PubMed ID: 19934487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.
    Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.